Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 EUR | +1.15% | -2.59% | -15.71% |
Apr. 23 | Maps, to group company project from Novara Health Authority | AN |
Mar. 28 | Futures tentatively up, eyes on macros | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.71% | 34.54M | - | ||
-17.25% | 185B | A- | ||
+1.01% | 167B | B+ | ||
+4.15% | 156B | B- | ||
+5.01% | 101B | A- | ||
+49.50% | 93.6B | C- | ||
+14.60% | 82.81B | A- | ||
-3.74% | 74.06B | A | ||
-1.87% | 46.26B | A- | ||
-34.05% | 43.02B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MAPS Stock
- Ratings Maps S.p.A.